• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

AON Announces Dr Stephen “Fred” Divers as New Chief Medical Officer

Article

American Oncology Network (AON) announced the appointment of Stephen "Fred" Divers, MD, a medical oncologist with Genesis Cancer and Blood Institute, as its new chief medical officer.

Fort Myers, Florida — American Oncology Network (AON) announced today, May 18, that Stephen "Fred" Divers, a medical oncologist with Genesis Cancer and Blood Institute, will serve as its new chief medical officer (CMO).

As CMO, Divers will play a vital role in furthering AON’s mission, providing leadership, strategy, and vision around practice transformation ensuring that its clinical model addresses patient needs. In addition to his new role as CMO, Dr. Divers will continue as AON Advisory Board Chairman and see patients at Genesis Cancer and Blood Institute.

“We are thrilled to announce Dr. Divers as our CMO,” said Todd Schonherz, chief executive officer, AON. “Since AON’s inception and as chairman of the AON Advisory Board, Dr Divers has been instrumental in leading the charge on ensuring patients have ready access to affordable, high quality cancer care in their local communities."

Learn more.

Related Videos
Chase D. Hendrickson, MD, MPH
Takiyah Durham, MBA, and Margaret Larkins-Pettigrew, MD
Afreen Idris Shariff, MD, MBBS, Duke Cancer Institute
 Brian Mullen, PhD, head of innovation and product, The Clinic by Cleveland Clinic
Mike Koroscik, MBA, MHA, Allina Health and the Allina Health Cancer Institute
Ted Okon, MBA, Community Oncology Alliance
dr erin gillaspie
Miriam J. Atkins, MD, FACP, Community Oncology Alliance/AO Multispecialty Clinic
Lalan Wilfongd, MD, US Oncology Network
Related Content
© 2023 MJH Life Sciences
AJMC®
All rights reserved.